{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:32:53Z","timestamp":1780471973222,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1136\/ard.2007.081653","type":"journal-article","created":{"date-parts":[[2008,1,5]],"date-time":"2008-01-05T01:54:12Z","timestamp":1199498052000},"page":"1431-1436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis"],"prefix":"10.1016","volume":"67","author":[{"given":"D","family":"Saadoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Resche-Rigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Sene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Perard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.081653_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia\u2014a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.081653_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8","article-title":"Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.","volume":"43","author":"De Vita","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081653_bib3","first-page":"79","article-title":"Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases.","volume":"28","author":"Gorevic","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1136\/ard.2007.081653_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.081653_bib5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/art.1780341221","article-title":"Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.","volume":"34","author":"Ferri","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081653_bib6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia.","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.081653_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9343(94)90132-5","article-title":"Mixed cryoglobulinemia and hepatitis C virus.","volume":"96","author":"Cacoub","year":"1994","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.081653_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.blre.2006.12.002","article-title":"Cryoglobulinemia.","volume":"21","author":"Tedeschi","year":"2007","journal-title":"Blood Rev"},{"key":"10.1136\/ard.2007.081653_bib9","first-page":"2078","article-title":"Treatment of hepatitis C virus-related systemic vasculitis.","volume":"32","author":"Cacoub","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081653_bib10","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1136\/ard.2007.081653_bib11","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study.","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081653_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081653_bib13","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ard.2007.081653_bib14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081653_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh470","article-title":"Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia.","volume":"44","author":"Catuogno","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.081653_bib16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","article-title":"Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.","volume":"80","author":"Basse","year":"2005","journal-title":"Transplantation"},{"key":"10.1136\/ard.2007.081653_bib17","first-page":"1197","article-title":"Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.","volume":"33","author":"Cai","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081653_bib18","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1080\/1042819031000119235","article-title":"Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.","volume":"44","author":"Zaja","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1136\/ard.2007.081653_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.081653_bib20","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2007.081653_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081653_bib22","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ard.2007.081653_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","article-title":"Characterization of cryoglobulins by immunoblotting.","volume":"38","author":"Musset","year":"1992","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2007.081653_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases.","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.081653_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"Pt 1","key":"10.1136\/ard.2007.081653_bib26","first-page":"15","article-title":"The French METAVIR Cooperative Study Group.","volume":"20","author":"Intraobserver","year":"1994","journal-title":"Hepatology"},{"key":"10.1136\/ard.2007.081653_bib27","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia.","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ard.2007.081653_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2257.2006.00779.x","article-title":"Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin\u2019s lymphoma patient.","volume":"28","author":"Aksoy","year":"2006","journal-title":"Clin Lab Haematol"},{"key":"10.1136\/ard.2007.081653_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2006-08-041525","article-title":"Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.","volume":"109","author":"Lake-Bakaar","year":"2007","journal-title":"Blood"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672442757X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672442757X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.081653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:53:21Z","timestamp":1737359601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672442757X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S000349672442757X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.081653","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.081653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}